Philip Morris Reaches Agreement to Continue Cigarette Production in Ukraine

Aug.04.2022
Philip Morris Reaches Agreement to Continue Cigarette Production in Ukraine
Fimo International will start producing cigarettes at the Imperial Tobacco factory in Kiev, allowing Philip Morris to maintain supply to clients.

According to reports from Ukraine's international news agency, Fimo International has reached an agreement with Imperial Tobacco to begin cigarette production at Imperial Tobacco's factory in Kiev this month.


This arrangement permits Philip Morris to continue supplying cigarettes to customers. Production at its Kharkiv factory had been suspended since the start of the Russia-Ukraine conflict, resulting in some cigarettes remaining unused due to difficulties with exporting.


Maksym Barabash, the Managing Director of Philip Morris International Ukraine, stated that since the onset of the conflict, they have been looking for alternative solutions to ensure the supply of their products. Barabash expressed delight in finding a mutually beneficial solution whereby Imperial Tobacco will produce products according to PMI's high-quality standards. This is a temporary measure for PMI, and they hope to resume production at their Kharkiv plant once worker safety is guaranteed.


Head of Ukraine's Imperial Tobacco Commission, Halyna Vorobyova, stated that "Kyiv's Imperial Tobacco factory has tremendous production potential and a strong professional team, which can ensure the production of more products." She added that "since the start of the war, our company has been unable to make export deliveries; therefore, the agreement with Philip Morris will allow us to utilize our production capacity.


Before the war, Philip Morris employed approximately 1,300 people. Its factory in Kharkov exports cigarettes to over 20 countries, including major markets like Japan and Egypt.


Statement:


This article is compiled from third-party information and is intended for industry communication and learning purposes only.


This article does not represent the views of 2FIRSTS, and 2FIRSTS cannot confirm the authenticity or accuracy of its contents. The article's translation is intended solely for industry exchange and research purposes.


Due to limitations in translation ability, the compiled article may not accurately represent the original text. Please refer to the original text for accuracy.


For any domestic, Hong Kong, Macau, Taiwan or foreign-related statements and positions, 2FIRSTS maintains complete alignment with the Chinese government.


The copyright for compiled information belongs to the original media and author. If there is any infringement, please contact us for removal.


This document has been generated through artificial intelligence translation and is provided solely for the purposes of industry discourse and learning. Please note that the intellectual property rights of the content belong to the original media source or author. Owing to certain limitations in the translation process, there may be discrepancies between the translated text and the original content. We recommend referring to the original source for complete accuracy. In case of any inaccuracies, we invite you to reach out to us with corrections. If you believe any content has infringed upon your rights, please contact us immediately for its removal.

UK OPSS launches vape safety campaign focusing on use, charging and disposal
UK OPSS launches vape safety campaign focusing on use, charging and disposal
The UK Office for Product Safety and Standards (OPSS) published information on March 4, 2026, launching a new campaign to raise awareness among young people about safety issues linked to using, charging and disposing of vapes.
Mar.06 by 2FIRSTS.ai
2Firsts Interview with Glas |Why a California ENDS Company Believes Its Age-gated Flavored Vape Could Be Next in Line for FDA Authorization
2Firsts Interview with Glas |Why a California ENDS Company Believes Its Age-gated Flavored Vape Could Be Next in Line for FDA Authorization
As the FDA advances efforts to streamline its PMTA review process, including support for small businesses, expectations are rising that additional product authorizations may follow. Age-verification technology is emerging as a key consideration in future approvals.In this interview, California-based Glas discusses its G2 platform, integrating smartphone-based identity verification, proximity controls and anti-counterfeit systems, and outlines its positioning under the FDA’s PMTA framework.
Mar.02
New York Nicotine Pouch Tax Moves Forward as Critics Question Public Health Impact
New York Nicotine Pouch Tax Moves Forward as Critics Question Public Health Impact
New York Governor Kathy Hochul included in her FY 2027 budget proposal a plan to impose the same 75% wholesale tax on nicotine pouches such as Zyn that applies to cigarettes. The measure is expected to raise USD 18 million in FY 2027 and USD 44 million in FY 2028 after full implementation.
Mar.30 by 2FIRSTS.ai
Ukrainian Committee Chair Says Nicotine Pouches Should Be Fully Banned for Sale to Minors
Ukrainian Committee Chair Says Nicotine Pouches Should Be Fully Banned for Sale to Minors
Mykhailo Radutskyi, chair of the Verkhovna Rada Committee on National Health, Medical Assistance and Medical Insurance, said nicotine pouches should be fully banned for sale to minors and their advertising should be restricted.
Apr.07 by 2FIRSTS.ai
Al Fakher Parent AIR Advances U.S. Listing Plan, With Deal Expected in First Half of 2026
Al Fakher Parent AIR Advances U.S. Listing Plan, With Deal Expected in First Half of 2026
AIR Limited and Cantor Equity Partners III, Inc. announced that AIR and AIR Holdings Limited have filed a Form F-4 registration statement with the U.S. Securities and Exchange Commission in connection with their previously announced proposed business combination. Upon closing, the combined company, AIR Global PLC, is expected to be listed on Nasdaq in the United States under the ticker symbol “AIIR.”
Mar.31 by 2FIRSTS.ai
PMTA Manufacturing Panel Sees Small Firms Warn “Unknown Is Death” as FDA Defends Review Boundaries
PMTA Manufacturing Panel Sees Small Firms Warn “Unknown Is Death” as FDA Defends Review Boundaries
During FDA’s Feb 10 PMTA roundtable (manufacturing controls panel), small ENDS manufacturers warned that uncertainty in manufacturing expectations creates existential financial risk. FDA officials reiterated review flexibility is constrained by statutory and scientific boundaries. The panel debated testing standards, documentation requirements, open-system responsibility, supply chain changes, and software updates—highlighting unresolved PMTA challenges for small manufacturers.
Feb.11